Kategorie:
PubID
Gen
MIM
25452615 Correira et al. BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma. Blood. 2015;125(4):658-667
BCL2
25713363 Green et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. PNAS USA. 2015; 112(10): E1116–E1125 23023713 Kridel et al. Pathogenesis of follicular lymphoma. J Clin Invest. 2012, 122(10): 3424–3343
CREBBP
25713363 Green et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. PNAS USA. 2015; 112(10): E1116–E1125 23023713 Kridel et al. Pathogenesis of follicular lymphoma. J Clin Invest. 2012, 122(10): 3424–3343
EP300
25713363 Green et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. PNAS USA. 2015; 112(10): E1116–E1125 23023713 Kridel et al. Pathogenesis of follicular lymphoma. J Clin Invest. 2012, 122(10): 3424–3343
EZH2
25713363 Green et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. PNAS USA. 2015; 112(10): E1116–E1125 23023713 Kridel et al. Pathogenesis of follicular lymphoma. J Clin Invest. 2012, 122(10): 3424–3343
KMT2D
23023713 Kridel et al. Pathogenesis of follicular lymphoma. J Clin Invest. 2012, 122(10): 3424–3343
MEF2B
TP53